Metabolomics is the large scale study of small molecules, or metabolites, in cells, tissues and biofluids. These molecules are the end products of gene expression and protein activity, so their patterns provide a direct snapshot of physiological state. Metabolomics typically focuses on amino acids, lipids, sugars, organic acids and many other intermediates of biochemical pathways.

Modern metabolomics relies on high resolution analytical platforms, mainly nuclear magnetic resonance spectroscopy and mass spectrometry coupled to chromatography. These techniques detect hundreds to thousands of metabolites at once, followed by computational processing, identification using spectral libraries and statistical modeling. Untargeted metabolomics screens broadly to discover unexpected changes, while targeted approaches quantify predefined metabolites with high accuracy.

Research spans many areas. In medicine, metabolomic profiles are being developed as biomarkers for early diagnosis, prognosis and treatment monitoring in cancer, cardiovascular disease, diabetes and neurodegenerative disorders. In nutrition, metabolomics links dietary components and gut microbiome activity to metabolic health, helping to personalize dietary recommendations. In toxicology, changes in metabolite patterns reveal mechanisms of drug toxicity and environmental exposure effects.

Plant and microbial metabolomics are used to study stress responses, improve crop traits and optimize biotechnological production of valuable compounds. Integrative “multi omics” strategies combine metabolomics with genomics, transcriptomics and proteomics to map how genetic variation and regulatory networks shape metabolism.

Key challenges include metabolite identification, coverage of chemically diverse compounds, standardization of methods and interpretation of massive datasets. Despite these hurdles, metabolomics is becoming a central tool for systems biology and precision medicine, offering a detailed, dynamic view of biochemical activity in living systems.